A pill that stimulated the body to mimic the effects of exercise—including endurance and weight control—could be on the horizon for individuals who are faced with frailty, movement disorders and other diseases that inhibit their ability to exercise.

Women diagnosed with preeclampsia during pregnancy are significantly more likely to develop risk factors for cardiovascular disease (CVD) including high blood pressure, diabetes and high cholesterol, according to a new study to be presented at the American College of Cardiology’s 67th Annual Scientific Session.

Self-monitoring was more useful than in-clinic blood pressure measurements for titrating antihypertensive medication, according to a randomized trial published online Feb. 27 in The Lancet. After one year, patients who underwent self-monitoring interventions showed significantly lower systolic blood pressures than those who were randomized to normal care.

A March 1 study in The Lancet: Diabetes & Endocrinology suggests patients should be divided into five subgroups by disease progression and complications. Such an approach could improve precision care for those early in treatment.

The “obesity paradox” suggests that people who are overweight or obese and diagnosed with cardiovascular disease (CVD) live longer than those with normal weight. A group of researchers debunked that theory, publishing their findings online Feb. 28 in JAMA Cardiology.

Diabetes in the United Kingdom has more than doubled since 1998, according to a new analysis by Diabetes UK.

A lacto-ovo-vegetarian diet and well-known Mediterranean diet are equally effective in reducing cardiovascular disease (CVD) risk factors, including body weight, body mass and fat mass, according to a new study published in the American Heart Association’s journal Circulation.

One in 7 American children develops obesity before entering kindergarten, according to an analysis of the latest national data from the Centers for Disease Control and Prevention.